Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Merck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say By: MarketWatch July 15, 2022 at 18:33 PM EDT Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized ahead of the pharmaceutical giant’s earnings later this month, though the talks remain on track, according to people familiar with the matter. Read More >> Related Stocks: Merck & Co Seagen Inc Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Merck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say By: MarketWatch July 15, 2022 at 18:33 PM EDT Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized ahead of the pharmaceutical giant’s earnings later this month, though the talks remain on track, according to people familiar with the matter. Read More >> Related Stocks: Merck & Co Seagen Inc